Antimicrobial resistance patterns and characterisation of emerging beta-lactamase-producing Escherichia coli in camels sampled from Northern Kenya.

Abstract in brief

• The study investigates antimicrobial resistance (AMR) in Escherichia coli (E. coli) from camels in Northern Kenya, highlighting the increase in resistant strains, especially those producing beta-lactamase enzymes, which can break down antibiotics.
• Researchers found high resistance levels to antibiotics like cefaclor, cefotaxime, and ampicillin, with about a third of samples containing extended-spectrum beta-lactamase (ESBL) producing E. coli, indicating multidrug resistance and potential health risks.
• The findings emphasize the need for a One Health approach—which considers human, animal, and environmental health—to better understand and manage AMR spread in camel husbandry, especially in arid and semi-arid regions with increasing camel populations and interactions.